Landscape → Infectious Disease

Influenza

701 clinical trials

156 active

701 total (since 2015)

Phase 1 Active

202 total

Phase 2 Active

211 total

Phase 3 Active

172 total

Phase 4 Active

172 total

Top Sponsors (Industry)

Sorted by active Active Done Failed

GSK 3 14 2

Sanofi 2 28 1

Valenta Pharm JSC 2 6 0

Shanghai Institute Of Biological Products 2 6 0

Jiangxi Qingfeng Pharmaceutical Co. Ltd. 2 4 0

Guangdong Raynovent Biotech Co., Ltd 2 3 0

Changchun BCHT Biotechnology Co. 2 1 0

LG Chem 2 1 0

CanSino Biologics Inc. 2 0 0

ModernaTX, Inc. 1 21 0

Seqirus 1 19 1

Sinovac Biotech Co., Ltd 1 8 0

Roche 1 7 0

Osivax 1 6 0

Cidara Therapeutics Inc. 1 2 0

NCT06087640 ACTIVE NOT RECRUITING

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Seqirus n=35,800

NCT07159763 ACTIVE NOT RECRUITING

A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza

Cidara Therapeutics Inc. n=7,500

NCT06094010 RECRUITING

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

Hoffmann-La Roche n=750

NCT06349668 RECRUITING

Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery

Hans Bahlmann n=220

NCT06648850 NOT YET RECRUITING

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

Applied Biology, Inc. n=800

NCT07211152 RECRUITING

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women

Sinovac Biotech Co., Ltd n=150

NCT07351500 NOT YET RECRUITING

Adaptive RCT of Corticosteroids for Severe Influenza Pneumonia in Adults

Qingyuan Zhan n=496

NCT07314905 NOT YET RECRUITING

Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)

Unity Health Toronto n=264

NCT07240558 RECRUITING

Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)

University Health Network, Toronto n=120

NCT07229820 ACTIVE NOT RECRUITING

Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A

Guangdong Raynovent Biotech Co., Ltd n=157

NCT07229807 ACTIVE NOT RECRUITING

Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A

Guangdong Raynovent Biotech Co., Ltd n=119

NCT07236814 NOT YET RECRUITING

Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting

Capital Medical University n=384

NCT07229547 NOT YET RECRUITING

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A.

Ruijin Hospital n=150

NCT06376916 RECRUITING

Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

Wake Forest University Health Sciences n=153

NCT07010107 RECRUITING

A Clinical Trial of Anaprazole for Treating Reflux Esophagitis.

Xuanzhu Biopharmaceutical Co., Ltd. n=500

NCT07133802 NOT YET RECRUITING

Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination

Changchun BCHT Biotechnology Co. n=6,680

NCT06255392 RECRUITING

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University n=200

NCT07113392 NOT YET RECRUITING

A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension

Jiangxi Kvvit Pharmaceutical Co., Ltd. n=144

NCT07093359 RECRUITING

LINX vs Fundoplication

University of Oxford n=460

NCT06947499 RECRUITING

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

LG Chem n=1,186

NCT06054269 ACTIVE NOT RECRUITING

Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP

Centers for Disease Control and Prevention n=192

NCT06160492 RECRUITING

Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)

Lee's Pharmaceutical Limited n=144

NCT06900972 ENROLLING BY INVITATION

Effect of Colloids Versus Crystalloids on Heart Mechanics: a Double-blind Cross Over Randomized Trial

University of Monastir n=16

NCT06276127 NOT YET RECRUITING

Oral Bisoprolol Vs IV Diltiazem in Atrial Fibrillation or Flutter With Rapid Ventricular Rate.

Oman Medical Speciality Board n=60

NCT06850480 RECRUITING

A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis

Livzon Pharmaceutical Group Inc. n=356

NCT06528444 RECRUITING

Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza

Instituto de Investigación Sanitaria y Biomédica de Alicante n=42

NCT06817096 NOT YET RECRUITING

Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza

Azidus Brasil n=340

NCT06800950 NOT YET RECRUITING

Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

Institute of Medical Biology, Chinese Academy of Medical Sciences n=4,400

NCT06653569 RECRUITING

Efficacy of Baloxavir Against Influenza in Hospitalized Patients: the INFLUENT Study (INpatients InFLUENza Treatment)

Dre Pauline Vetter n=484

NCT06574503 RECRUITING

Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza

Jiangxi Qingfeng Pharmaceutical Co. Ltd. n=748

NCT06573008 RECRUITING

Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications

Jiangxi Qingfeng Pharmaceutical Co. Ltd. n=328

NCT03808922 RECRUITING

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

Ansun Biopharma, Inc. n=274

NCT05622162 ACTIVE NOT RECRUITING

Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7

ITEL Telecomunicazioni Srl n=106

NCT04150458 ENROLLING BY INVITATION

Fluorocholine PET/CT Basket Trial

Sir Mortimer B. Davis - Jewish General Hospital n=2,000

NCT04615156 NOT YET RECRUITING

18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography

Eastern Health, Canada n=10,000

NCT03553563 COMPLETED

A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer

AstraZeneca n=50

NCT04457297 COMPLETED

Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection

National Cancer Center Hospital East n=243

NCT07326904 COMPLETED

Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease

Indonesia University n=145

NCT05645900 COMPLETED

A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months

Ab&B Bio-tech Co., Ltd.JS n=2,772

NCT04544267 TERMINATED

Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age

Sanofi Pasteur, a Sanofi Company n=100

NCT06178991 COMPLETED

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

BioNTech SE n=8,795

NCT06641180 COMPLETED

Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age

Sanofi Pasteur, a Sanofi Company n=1,180

NCT06694389 COMPLETED

Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age

ModernaTX, Inc. n=2,457

NCT05890001 COMPLETED

A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease

Braintree Laboratories n=400

NCT06507813 COMPLETED

Safety and Efficacy of ADC189 in Children 2-11 Years Old With Influenza

Jiaxing AnDiCon Biotech Co.,Ltd n=190

NCT05118672 COMPLETED

Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment

Eurofarma Laboratorios S.A. n=567

NCT04429295 COMPLETED

Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand

Sanofi Pasteur, a Sanofi Company n=460

NCT05779020 COMPLETED

Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .

Butantan Institute n=1,373

NCT04210349 COMPLETED

Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age

Sanofi Pasteur, a Sanofi Company n=7,106

NCT06602024 COMPLETED

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

ModernaTX, Inc. n=40,817

NCT03015610 COMPLETED

Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma

Jason Lang, M.D., M.P.H. n=41

NCT06049927 COMPLETED

A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

Sinovac Biotech Co., Ltd n=3,300

NCT07079540 COMPLETED

The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis

Jiangsu Sinorda Biomedicine Co., Ltd n=380

NCT05827978 COMPLETED

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

ModernaTX, Inc. n=8,411

NCT03969212 COMPLETED

Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households

Hoffmann-La Roche n=4,138

NCT06097273 COMPLETED

A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age

ModernaTX, Inc. n=8,061

NCT03787459 COMPLETED

Severe Influenza Trial of ARbidol

Capital Medical University n=200

NCT05482282 WITHDRAWN

Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)

PT Bio Farma

NCT05071313 COMPLETED

A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older

Janssen Vaccines & Prevention B.V. n=777

NCT06774859 COMPLETED

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza Symptoms

Hoffmann-La Roche n=100

NCT05540522 COMPLETED

A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older

Pfizer n=45,789

NCT06183229 COMPLETED

Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza

POLYSAN Scientific & Technological Pharmaceutical Company n=166

NCT06015282 COMPLETED

The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older

Seqirus n=7,741

NCT06482359 WITHDRAWN

Lot Consistency Study of COVID-19 and Influenza Combination Vaccine

Novavax

NCT03932682 COMPLETED

Efficacy Study With QIVc in Pediatric Subjects

Seqirus n=5,723

NCT05170009 TERMINATED

Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza

Weill Medical College of Cornell University n=2

NCT03927131 COMPLETED

Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine

Butantan Institute n=5,822

NCT03376321 TERMINATED

A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection

Janssen Research & Development, LLC n=334

NCT03381196 TERMINATED

A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications

Janssen Research & Development, LLC n=553

NCT05566639 COMPLETED

A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older

ModernaTX, Inc. n=22,502

NCT02839330 COMPLETED

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

Seqirus n=3,196

NCT05702489 COMPLETED

A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

Nanjing Zenshine Pharmaceuticals n=900

NCT03849560 COMPLETED

Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in Volunteers

NPO Petrovax n=612

NCT05415462 COMPLETED

A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

ModernaTX, Inc. n=6,102

NCT05587322 COMPLETED

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease

Braintree Laboratories n=800

NCT05431725 COMPLETED

Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

Sinovac Biotech Co., Ltd n=2,202

NCT05245552 COMPLETED

A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

Sinovac Biotech Co., Ltd n=217

NCT02624765 COMPLETED

Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)

Edgar Jaeggi n=105

NCT03653364 COMPLETED

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms

Hoffmann-La Roche n=49

NCT06385821 COMPLETED

A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

NPO Petrovax n=824

NCT05642078 COMPLETED

Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. n=2,550

NCT03744104 COMPLETED

A Clinical Trial of A Quadrivalent Influenza Vaccine

Shanghai Institute Of Biological Products n=2,688

NCT05195528 COMPLETED

A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)

Phathom Pharmaceuticals, Inc. n=776

NCT05474755 COMPLETED

To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection

Jiangxi Qingfeng Pharmaceutical Co. Ltd. n=591

NCT05544916 COMPLETED

A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Valenta Pharm JSC n=260

NCT05044195 COMPLETED

A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of Age

Seqirus n=2,044

NCT02677493 COMPLETED

Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.'

Il-Yang Pharm. Co., Ltd. n=1,794

NCT04250311 SUSPENDED

Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

Materia Medica Holding n=314

NCT03301051 COMPLETED

Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults

Medicago n=10,160

NCT03310125 COMPLETED

Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)

Population Health Research Institute n=3,209

NCT03321968 COMPLETED

Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults

Medicago n=1,202

NCT05269290 COMPLETED

Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

Valenta Pharm JSC n=240

NCT05273619 COMPLETED

Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Valenta Pharm JSC n=250

NCT04695717 COMPLETED

This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam

Vietnam Military Medical University n=864

NCT04683406 COMPLETED

A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A

Guangdong Raynovent Biotech Co., Ltd n=750

NCT05871398 COMPLETED

The Efficacy of Potassium-competitive Acid Blocker in Patients With Laryngopharyngeal Reflux Disease

Pusan National University Hospital n=36

NCT05869201 COMPLETED

Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine

St. Petersburg Research Institute of Vaccines and Sera n=450

NCT04120194 COMPLETED

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

Novavax n=2,654

NCT05813561 COMPLETED

The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis

Daewoong Pharmaceutical Co. LTD. n=332

NCT04077970 COMPLETED

Intrauterine Flushing With Follicular Fluid Plus Granulosa Cells

Royan Institute n=140

NCT04870073 WITHDRAWN

Retrograde Autologous Priming and Mannitol for Reducing Hemodilution in Cardiac Surgery

Hamilton Health Sciences Corporation

NCT05069714 COMPLETED

One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis.

Seoul National University Hospital n=184

NCT04325620 COMPLETED

Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease

Hanmi Pharmaceutical Company Limited n=208

NCT05308212 COMPLETED

Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra

St. Petersburg Research Institute of Vaccines and Sera n=633

NCT05470582 COMPLETED

Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old

St. Petersburg Research Institute of Vaccines and Sera n=1,066

NCT05457894 COMPLETED

Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women

St. Petersburg Research Institute of Vaccines and Sera n=207

NCT03336619 COMPLETED

A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza

Romark Laboratories L.C. n=1,030

NCT05417997 COMPLETED

Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients

RAAS Nutritionals, LLC n=71

NCT03704740 COMPLETED

Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months

SK Bioscience Co., Ltd. n=676

NCT03391193 COMPLETED

Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine

Sanofi Pasteur, a Sanofi Company n=301

NCT03765437 COMPLETED

Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam

Sanofi Pasteur, a Sanofi Company n=230

NCT02451358 COMPLETED

Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India

Sanofi Pasteur, a Sanofi Company n=400

NCT03153150 COMPLETED

Start or STop Anticoagulants Randomised Trial (SoSTART)

University of Edinburgh n=203

NCT05317767 COMPLETED

The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years.

St. Petersburg Research Institute of Vaccines and Sera n=600

NCT03282240 COMPLETED

Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US

Sanofi Pasteur, a Sanofi Company n=2,670

NCT05312294 COMPLETED

Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years

St. Petersburg Research Institute of Vaccines and Sera n=654

NCT02428491 COMPLETED

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

Sanofi Pasteur, a Sanofi Company n=354

NCT02550197 COMPLETED

Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Given by Intramuscular Route in Subjects Aged 18 to 60 Years

Sanofi Pasteur, a Sanofi Company n=300

NCT04074928 COMPLETED

Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects

Seqirus n=2,414

NCT05089123 COMPLETED

The Objectives of This Study Are Study the Immunogenicity and Safety of the Flu-M [Inactivated Split Influenza Vaccine], vs. the Ultrix® Inactivated Split Influenza Vaccine, in Volunteers Who Are Over 60 Years Old

St. Petersburg Research Institute of Vaccines and Sera n=320

NCT03450915 COMPLETED

A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine

BiondVax Pharmaceuticals ltd. n=12,460

NCT02345681 COMPLETED

Impact of Rational Control of Fluid Balance in the Intensive Care Unit

Nantes University Hospital n=171

NCT03967886 COMPLETED

Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

Yooyoung Pharmaceutical Co., Ltd. n=170

NCT02369159 COMPLETED

Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

BioCryst Pharmaceuticals n=137

NCT02635724 COMPLETED

Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza

BioCryst Pharmaceuticals n=74

NCT04806529 WITHDRAWN

An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older

Seqirus

NCT03684044 COMPLETED

Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza

Hoffmann-La Roche n=363

NCT03444883 COMPLETED

Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD

Il-Yang Pharm. Co., Ltd. n=277

NCT03699839 COMPLETED

Reducing the Burden of Influenza After Solid-Organ Transplantation

Oriol Manuel n=619

NCT03139565 COMPLETED

High Dose vs. Standard Influenza Vaccine in Adult SOT

University Health Network, Toronto n=172

NCT03165617 COMPLETED

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age

Seqirus n=4,514

NCT03314662 COMPLETED

Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults

Seqirus n=1,778

NCT02587221 COMPLETED

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age

Seqirus n=6,790

NCT03445468 COMPLETED

Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents

Il-Yang Pharm. Co., Ltd. n=379

NCT03629184 COMPLETED

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms

Hoffmann-La Roche n=173

NCT03390166 COMPLETED

Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

Mahidol University n=945

NCT03591653 COMPLETED

A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. n=291

NCT03118362 COMPLETED

Fluid Resuscitation in Burn Patients

Assistance Publique - Hôpitaux de Paris n=28

NCT02949011 COMPLETED

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications

Shionogi n=2,184

NCT02287467 COMPLETED

Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza

National Institute of Allergy and Infectious Diseases (NIAID) n=329

NCT03460743 COMPLETED

Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

Laboratorios Liomont n=1,556

NCT02858440 COMPLETED

A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia

GlaxoSmithKline n=235

NCT04101435 COMPLETED

Immunogenicity and Safety Evaluation of QIS in Healthy Subjects

Adimmune Corporation n=174

NCT02891070 COMPLETED

Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery

Baxter Healthcare Corporation n=224

NCT03718468 COMPLETED

A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine

Medigen Vaccine Biologics Corp. n=842

NCT03095599 COMPLETED

Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) - PHASE 2/3

Institute of Vaccines and Medical Biologicals, Vietnam n=889

NCT02572817 COMPLETED

Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A

National Institute of Allergy and Infectious Diseases (NIAID) n=138

NCT02612909 COMPLETED

A Safety and Immunogenicity Study of IVACFLU-A/H5N1

Institute of Vaccines and Medical Biologicals, Vietnam n=930

NCT02954354 COMPLETED

A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza

Shionogi n=1,436

NCT02583256 COMPLETED

Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989)

Seqirus n=1,601

NCT02935192 COMPLETED

Phase 3 Trial of Serbian Seasonal Influenza Vaccine

Institute of Virology, Vaccines and Sera, Torlak n=480

NCT03881722 COMPLETED

Effect of Magnesium Alginate in Infants With Gastroesophageal Reflux.

Policlinico Hospital n=89

NCT03859141 COMPLETED

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

Sinovac Biotech Co., Ltd n=2,340

NCT03853993 COMPLETED

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

Sinovac Biotech Co., Ltd n=2,380

NCT02914275 COMPLETED

A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.

Seqirus n=2,250

NCT02457546 COMPLETED

The EVICEL® Neurosurgery Phase III Study

Ethicon, Inc. n=234

NCT03572491 COMPLETED

Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine

Research Institute for Biological Safety Problems n=2,000

NCT02545543 COMPLETED

A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age

Seqirus n=2,278

NCT02556021 COMPLETED

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease

HK inno.N Corporation n=324

NCT02612922 COMPLETED

Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Romark Laboratories L.C. n=325

NCT03441373 COMPLETED

XC8 in the Treatment of Patients With Acute Respiratory Viral Infection

PHARMENTERPRISES LLC n=320

NCT03215797 COMPLETED

Phenylephrine or Norepinephrine for a Better Hemodynamic Stability

The Second Affiliated Hospital of Dalian Medical University n=40

NCT03128489 WITHDRAWN

Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants

GlaxoSmithKline

NCT03020628 COMPLETED

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months

SK Chemicals Co., Ltd. n=171

NCT02369341 COMPLETED

Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above

GlaxoSmithKline n=121

NCT02366962 COMPLETED

A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older

UMN Pharma Inc. n=55

NCT02964065 COMPLETED

A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV)

Changchun BCHT Biotechnology Co. n=9,000

NCT02917304 COMPLETED

A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older

Green Cross Corporation n=274

NCT02381418 COMPLETED

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season

Abbott n=120

NCT02541253 COMPLETED

A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children

Green Cross Corporation n=543

NCT02710409 COMPLETED

A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older

Jiangsu Province Centers for Disease Control and Prevention n=3,664

NCT02644018 COMPLETED

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o.

Valenta Pharm JSC n=190

NCT06815666 RECRUITING

BAL Fluid Biomarkers in Sarcoma

University Health Network, Toronto

NCT07215858 NOT YET RECRUITING

BPL-1357 Against H1N1 Influenza Virus Challenge

National Institute of Allergy and Infectious Diseases (NIAID)

NCT06957691 RECRUITING

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Shehzad Basaria, M.D.

NCT07420985 RECRUITING

Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.

Valenta Pharm JSC

NCT05648448 RECRUITING

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

University of Oxford

NCT04712539 RECRUITING

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

M.D. Anderson Cancer Center

NCT04383262 NOT YET RECRUITING

Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction

Medical College of Wisconsin

NCT07371650 ACTIVE NOT RECRUITING

This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza

Traws Pharma, Inc.

NCT06906471 NOT YET RECRUITING

A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

Antelope Surgical Solutions, Inc

NCT04613206 ACTIVE NOT RECRUITING

High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients

Vanderbilt University Medical Center

NCT07327398 NOT YET RECRUITING

Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above

Shanghai Institute Of Biological Products

NCT05556824 RECRUITING

Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD

Microbiome Health Sciences

NCT07291635 NOT YET RECRUITING

Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine

Aramis Biotechnologies Inc.

NCT07128615 ACTIVE NOT RECRUITING

A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

AstraZeneca

NCT05569239 ACTIVE NOT RECRUITING

Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg

Osivax

NCT05215327 RECRUITING

High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

Vanderbilt University Medical Center

NCT07204964 RECRUITING

A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

GlaxoSmithKline

NCT06824519 RECRUITING

Clinical Trials of Quadrivalent Influenza Vaccine

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

NCT07121192 ACTIVE NOT RECRUITING

A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

GlaxoSmithKline

NCT06258525 NOT YET RECRUITING

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Cedars-Sinai Medical Center

NCT07192458 RECRUITING

High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)

Vanderbilt University Medical Center

NCT06842173 RECRUITING

Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults

Butantan Institute

NCT07174947 NOT YET RECRUITING

SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety

First Affiliated Hospital of Wenzhou Medical University

NCT05386394 RECRUITING

Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia

Johns Hopkins University

NCT07033481 RECRUITING

Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia

EIP Pharma Inc

NCT06599658 RECRUITING

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

McGill University Health Centre/Research Institute of the McGill University Health Centre

NCT07036406 RECRUITING

Comparing Traditional Semantic Feature Analysis (tSFA) and Semantic Feature Analysis + Metacognitive Strategy Training (SFA+MST)

Teachers College, Columbia University

NCT06684379 RECRUITING

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

PEACHES BIOTECH

NCT05291676 RECRUITING

Systems Investigation of Vaccine Responses in Aging and Frailty

Yale University

NCT06744205 ACTIVE NOT RECRUITING

A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older

Sanofi Pasteur, a Sanofi Company

NCT01677689 NOT YET RECRUITING

Study to Investigate the Efficacy and Safety of Apomivir®

Far East Bio-Tec Co., Ltd

NCT05884866 RECRUITING

A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.

Klinikum Nürnberg

NCT05947071 RECRUITING

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

National Institute of Allergy and Infectious Diseases (NIAID)

NCT04494412 RECRUITING

An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection

GlaxoSmithKline

NCT06809413 ENROLLING BY INVITATION

Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease

Beijing Chest Hospital

NCT05895955 ACTIVE NOT RECRUITING

Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais

Mahidol University

NCT06626984 NOT YET RECRUITING

Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis

Belfast Health and Social Care Trust

NCT06618196 NOT YET RECRUITING

Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age

LG Chem

NCT06540352 RECRUITING

A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

NCT06370975 NOT YET RECRUITING

Effect of Fluid Resuscitation on Lactate in Traumatic Injury Patients

Assiut University

NCT06317675 RECRUITING

Osteopathic Manipulative Treatment for Gastro-oesophageal Reflux Disease

Studio Osteopatico Busto Arsizio

NCT06326112 NOT YET RECRUITING

Role of Active Deresuscitation After Resuscitation:

Unity Health Toronto

NCT06174012 NOT YET RECRUITING

The Effect of Sodium Fluoride Application on the Prevention of Radiation Caries in NPC Patients

Sun Yat-sen University

NCT05937191 RECRUITING

Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

NCT05583955 COMPLETED

A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)

Noema Pharma AG

NCT06382311 COMPLETED

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

GlaxoSmithKline

NCT06821061 COMPLETED

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

BioNTech SE

NCT06436703 COMPLETED

A Study About Modified RNA Vaccines Against Influenza in Healthy Adults

Pfizer

NCT06560151 COMPLETED

Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59

Biomedical Advanced Research and Development Authority

NCT05827926 COMPLETED

A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults

ModernaTX, Inc.

NCT06431607 COMPLETED

A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults

GlaxoSmithKline

NCT05606965 COMPLETED

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults

ModernaTX, Inc.

NCT06656026 COMPLETED

Pharmacokinetics，Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A

Guangdong Raynovent Biotech Co., Ltd

NCT04364854 COMPLETED

Speech Entrainment for Aphasia Recovery

Medical University of South Carolina

NCT06609460 COMPLETED

Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications

Cidara Therapeutics Inc.

NCT06864143 COMPLETED

A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

ModernaTX, Inc.

NCT06508320 COMPLETED

A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)

ModernaTX, Inc.

NCT06237049 COMPLETED

A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

Pfizer

NCT05608005 COMPLETED

Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older

Sanofi Pasteur, a Sanofi Company

NCT05901636 COMPLETED

A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults

Janssen Vaccines & Prevention B.V.

NCT04398706 COMPLETED

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Sanofi Pasteur, a Sanofi Company

NCT05975840 COMPLETED

Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults

GlaxoSmithKline

NCT06683352 COMPLETED

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

BioNTech SE

NCT06160531 COMPLETED

Influenza Viral Challenge Study of CC-42344 in Healthy Participants

Cocrystal Pharma, Inc.

NCT02907983 WITHDRAWN

Stellate Ganglion Blockade in Post-Menopausal Women

Northwestern University

NCT05823974 COMPLETED

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

GlaxoSmithKline

NCT05596734 COMPLETED

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza

BioNTech SE

NCT04614974 TERMINATED

Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia

Reema Padia

NCT04531475 COMPLETED

Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis

Jiangsu Sinorda Biomedicine Co., Ltd

NCT05972174 COMPLETED

A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults

ModernaTX, Inc.

NCT06582277 COMPLETED

Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836

Osivax

NCT06614361 WITHDRAWN

Community-based Behavioral Intervention to Increase Vaccination Using MOST

New York University

NCT03941405 COMPLETED

Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)

Fundacion Clinic per a la Recerca Biomédica

NCT05827068 COMPLETED

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

ModernaTX, Inc.

NCT04850898 COMPLETED

Study of SAB-176 in Healthy Adult Participants

SAb Biotherapeutics, Inc.

NCT04441047 COMPLETED

Universal Anti-Viral Vaccine for Healthy Elderly Adults

Mirror Biologics, Inc.

NCT05868382 COMPLETED

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults

ModernaTX, Inc.

NCT05874713 COMPLETED

Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults

Seqirus

NCT02834312 COMPLETED

E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)

Donesta Bioscience

NCT05284799 COMPLETED

Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers.

Osivax

NCT05507567 COMPLETED

Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model

Pneumagen Ltd.

NCT02860039 COMPLETED

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Vanderbilt-Ingram Cancer Center

NCT03755427 COMPLETED

A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine

Shanghai Institute Of Biological Products

NCT03369808 COMPLETED

A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine

Shanghai Institute Of Biological Products

NCT04782323 COMPLETED

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults

Seqirus

NCT02921997 COMPLETED

H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses

National Institute of Allergy and Infectious Diseases (NIAID)

NCT05523089 COMPLETED

The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults

Cidara Therapeutics Inc.

NCT03312231 COMPLETED

Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly

National Institute of Allergy and Infectious Diseases (NIAID)

NCT05567783 TERMINATED

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

Vir Biotechnology, Inc.

NCT05519839 COMPLETED

A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine

Novavax

NCT04933968 TERMINATED

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

AlloVir

NCT03232567 COMPLETED

Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX

Altimmune, Inc.

NCT04576702 COMPLETED

Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults

Seqirus

NCT05501561 COMPLETED

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age

Seqirus

NCT03315104 COMPLETED

Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A

Emergent BioSolutions

NCT04071171 COMPLETED

Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation

Medical University Innsbruck

NCT04669691 COMPLETED

A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine

Seqirus

NCT05052697 COMPLETED

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

Pfizer

NCT05375838 COMPLETED

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old

ModernaTX, Inc.

NCT05981846 COMPLETED

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

Hipra Scientific, S.L.U

NCT05333289 COMPLETED

A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

ModernaTX, Inc.

NCT05734040 COMPLETED

Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

Osivax

NCT04363359 COMPLETED

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

Shanghai Institute Of Biological Products

NCT02529904 COMPLETED

ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults

University of Oxford

NCT04956575 COMPLETED

A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

ModernaTX, Inc.

NCT04789577 COMPLETED

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older

GlaxoSmithKline

NCT05273658 WITHDRAWN

Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests

University of California, San Diego

NCT05060887 COMPLETED

Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers.

Osivax

NCT05422326 COMPLETED

A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed

Seqirus

NCT05030324 COMPLETED

A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Valenta Pharm JSC

NCT04622592 COMPLETED

Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older

Medicago

NCT05111392 COMPLETED

Hydration Dynamics and Influence of Beverage Composition

University of Illinois at Chicago

NCT05082688 COMPLETED

Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)

Radboud University Medical Center

NCT02513329 COMPLETED

Stellate Ganglion Block (SGB) For Women for Breast Cancer

Northwestern University

NCT03669627 COMPLETED

CT18 Infant Influenza Priming Study in Vaccine Naive Infants

Canadian Immunization Research Network

NCT03994406 COMPLETED

Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel

Glia, LLC

NCT03212716 TERMINATED

Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.

University Hospital, Lille

NCT04610047 COMPLETED

Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness

Emergo Therapeutics, Inc.

NCT05255822 COMPLETED

INNA-051 Influenza Challenge Study

ENA Respiratory Pty Ltd

NCT04799158 COMPLETED

A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease

Phathom Pharmaceuticals, Inc.

NCT03040141 COMPLETED

Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A

Visterra, Inc.

NCT03293498 COMPLETED

Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu)

Novavax

NCT03658629 TERMINATED

Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults

Novavax

NCT03511066 TERMINATED

A Study to Evaluate the Efficacy and Safety of CT-P27 in Acute Uncomplicated Influenza A Infection

Celltrion

NCT02918006 COMPLETED

A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

Vaxart

NCT04192500 COMPLETED

Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years

Osivax

NCT05048589 COMPLETED

Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting

Tor Biering-Sørensen

NCT05502458 COMPLETED

Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

Zhejiang Cancer Hospital

NCT02989194 COMPLETED

Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A

Visterra, Inc.

NCT03122301 TERMINATED

Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer

Northwestern University

NCT04736758 COMPLETED

A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

NCT04492956 COMPLETED

Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)

Emalex Biosciences Inc.

NCT03233217 COMPLETED

Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years

Sanofi Pasteur, a Sanofi Company

NCT03698279 COMPLETED

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Sanofi Pasteur, a Sanofi Company

NCT05297994 COMPLETED

Trial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBA

St. Petersburg Research Institute of Vaccines and Sera

NCT04706468 COMPLETED

To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection

TaiGen Biotechnology Co., Ltd.

NCT05269329 COMPLETED

Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Valenta Pharm JSC

NCT04351061 WITHDRAWN

Acetazolamide for the Prevention of Post Operative CSF Leak

University of Miami

NCT05095545 COMPLETED

Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza

Viriom

NCT03589807 COMPLETED

2013/2017 H7N9 Prime-Boost Interval

National Institute of Allergy and Infectious Diseases (NIAID)

NCT03738241 COMPLETED

2017 A/H7N9 IIV Revaccination

National Institute of Allergy and Infectious Diseases (NIAID)

NCT03276975 COMPLETED

A Randomized Trial of CT Fluoroscopy-guided Targeted Autologous Blood and Fibrin Glue Patching for Treatment

Duke University

NCT03682120 COMPLETED

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

National Institute of Allergy and Infectious Diseases (NIAID)

NCT02668185 COMPLETED

Neuropeptide Treatment for Hot Flushes During the Menopause

Imperial College London

NCT03880474 TERMINATED

Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults

Barinthus Biotherapeutics

NCT04043923 COMPLETED

Norketotifen for the Treatment of Uncomplicated Influenza-like Illness

Emergo Therapeutics, Inc.

NCT03883113 COMPLETED

Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge Model

Barinthus Biotherapeutics

NCT03425097 TERMINATED

Fexofenadine Use in Gastroesophageal Reflux Symptoms

Stanford University

NCT04637308 COMPLETED

Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy

Guangdong Provincial People's Hospital

NCT03830905 COMPLETED

Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI

PHARMENTERPRISES LLC

NCT03845231 COMPLETED

Mucosal and Systemic Immunity After Viral Challenge of Healthy Volunteers Vaccinated With Inactivated Influenza Vaccine Via the Intranasal Versus Intramuscular Route

National Institute of Allergy and Infectious Diseases (NIAID)

NCT02962908 COMPLETED

A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine

PepTcell Limited

NCT02867358 COMPLETED

A Clinical Trial of KT07 Capsule in the U.S.A

Yiling Pharmaceutical Inc.

NCT02680002 COMPLETED

Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant

Biomedical Advanced Research and Development Authority

NCT02480998 COMPLETED

Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults

Il-Yang Pharm. Co., Ltd.

NCT03318315 COMPLETED

Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4

National Institute of Allergy and Infectious Diseases (NIAID)

NCT03180801 COMPLETED

Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model

PepTcell Limited

NCT03497845 COMPLETED

Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59

Biomedical Advanced Research and Development Authority

NCT03058692 COMPLETED

Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine

National Institute of Allergy and Infectious Diseases (NIAID)

NCT04024137 COMPLETED

Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A

Guangdong Raynovent Biotech Co., Ltd

NCT03283319 COMPLETED

Panblok H7 Vaccine Adjuvanted With AS03 or MF59

Biomedical Advanced Research and Development Authority

NCT02902133 WITHDRAWN

Acetazolamide to Prevent Post Operative CSF Leak

University of Miami

NCT02532283 COMPLETED

A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection

Janssen Research & Development, LLC

NCT02894840 COMPLETED

Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

Mahidol University

NCT02743949 COMPLETED

Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)

Takeda

NCT03903718 WITHDRAWN

Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza

MedImmune LLC

NCT03220048 COMPLETED

Study Examining PrEP-001 in Healthy Subjects

Hvivo

NCT03455491 COMPLETED

Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections

PHARMENTERPRISES LLC

NCT02719743 COMPLETED

A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age

GlaxoSmithKline

NCT03144817 COMPLETED

Dialysate Sodium Lowering Trial

Tufts Medical Center

NCT03394209 COMPLETED

A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza

Capital Medical University

NCT03028909 WITHDRAWN

Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.

MedImmune LLC

NCT02998996 COMPLETED

Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU

Eurocine Vaccines AB

NCT02566265 COMPLETED

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients

Yale University

NCT02623322 COMPLETED

A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults

Genentech, Inc.

NCT03657719 COMPLETED

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects

Green Cross Corporation

NCT03784885 COMPLETED

A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult

Advagene Biopharma Co. Ltd.

NCT03437304 COMPLETED

Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU in Older Adults

Eurocine Vaccines AB

NCT03300362 TERMINATED

Improved Novel VaccIne CombinaTion InflUenza Study

Barinthus Biotherapeutics

NCT03727607 COMPLETED

TIVA Versus Desfluran Anaesthesia in Patients Undergoing Bariatric Surgery

Ostfold Hospital Trust

NCT02586792 COMPLETED

H7N9 Boost in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT02293863 COMPLETED

A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection

Genentech, Inc.

NCT02603952 COMPLETED

A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza

MedImmune LLC

NCT03016143 COMPLETED

Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)

Research Institute for Biological Safety Problems

NCT02786810 COMPLETED

Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy

University of Tennessee

NCT02553343 COMPLETED

A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older

Sanofi Pasteur, a Sanofi Company

NCT02691130 COMPLETED

Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults

BiondVax Pharmaceuticals ltd.

NCT02464163 COMPLETED

Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older

Protein Sciences Corporation

NCT02960815 COMPLETED

Imiquimod and Influenza Vaccine for Immunocompromised Patients

University of Lausanne Hospitals

NCT02423577 COMPLETED

Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain

Autoimmune Technologies, LLC

NCT02463643 COMPLETED

To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis

Zeria Pharmaceutical

NCT02555618 COMPLETED

Phase 2 Study of TAK-850 in Comparison With Influenza Hemagglutinin (HA) Vaccine in Healthy Adult Participants

Takeda

NCT02713061 WITHDRAWN

A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants

Takeda

NCT02436928 COMPLETED

A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects

Medigen Vaccine Biologics Corp.

NCT02367885 COMPLETED

Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants

Takeda

NCT02468115 COMPLETED

Influenza Challenge Study of VIS410 in Healthy Volunteers

Visterra, Inc.

NCT02427750 COMPLETED

A Study to Evaluate Safety and Immunogenicity of Trivalent Influenza Vaccine, Formulation 2015 Southern Hemisphere, When Administered to Healthy Adult Subjects.

Novartis

NCT07215871 ENROLLING BY INVITATION

Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza

National Institute of Allergy and Infectious Diseases (NIAID)

NCT06753474 RECRUITING

A/Texas Flu Challenge

Emory University

NCT06863142 RECRUITING

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT07421050 ACTIVE NOT RECRUITING

Clinical Trial of Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older

Ab&B Bio-tech Co., Ltd.JS

NCT07421037 ACTIVE NOT RECRUITING

Clinical Trial of Quadrivalent Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older

Ab&B Bio-tech Co., Ltd.JS

NCT05945485 ACTIVE NOT RECRUITING

A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT07019883 ACTIVE NOT RECRUITING

A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT07169318 RECRUITING

First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics

National Institute of Allergy and Infectious Diseases (NIAID)

NCT07110532 RECRUITING

pH1N1 Blinded Challenge Study

National Institute of Allergy and Infectious Diseases (NIAID)

NCT06604767 ACTIVE NOT RECRUITING

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Sanofi Pasteur, a Sanofi Company

NCT07111078 RECRUITING

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT07349017 NOT YET RECRUITING

A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant)

Changchun BCHT Biotechnology Co.

NCT07302256 RECRUITING

A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above

Shanghai Institute Of Biological Products

NCT07340047 NOT YET RECRUITING

H1ssF Flu Vaccine Clinical Trial

University of Minnesota

NCT07203755 RECRUITING

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

CanSino Biologics Inc.

NCT04366115 NOT YET RECRUITING

Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS

AVM Biotechnology Inc

NCT06355232 RECRUITING

Covid-19 and Influenza Oral Vaccine Study

Vaxine Pty Ltd

NCT06621654 ACTIVE NOT RECRUITING

Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine

CanSino Biologics Inc.

NCT07063849 ACTIVE NOT RECRUITING

Pilot Influenza Challenge Study

Daniel Hoft, MD, PhD

NCT06859333 RECRUITING

Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers

Valenta Pharm JSC

NCT06460064 ACTIVE NOT RECRUITING

First-in-human Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LP

Sumitomo Pharma Co., Ltd.

NCT04896853 ACTIVE NOT RECRUITING

Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

NextCell Pharma Ab

NCT06465420 ACTIVE NOT RECRUITING

A Study to Evaluate Safety and Immunogenicity of Haemophilus Influenzae Serotype A Vaccine

InventVacc Biologicals Inc.

NCT02404688 ACTIVE NOT RECRUITING

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition

Yale University

NCT02710097 ACTIVE NOT RECRUITING

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II

Yale University

NCT02709954 ACTIVE NOT RECRUITING

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I

Yale University

NCT02710331 ACTIVE NOT RECRUITING

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III

Yale University

NCT05332899 RECRUITING

Influenza Human Challenge Model

Emory University

NCT05397223 ACTIVE NOT RECRUITING

A Study of Modified mRNA Vaccines in Healthy Adults

ModernaTX, Inc.

NCT06417853 ACTIVE NOT RECRUITING

Influenza a (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)

Vaxxas Pty Ltd

NCT06622590 ACTIVE NOT RECRUITING

Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

Institute of Medical Biology, Chinese Academy of Medical Sciences

NCT06235125 RECRUITING

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children

Ann & Robert H Lurie Children's Hospital of Chicago

NCT06546423 RECRUITING

Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vaccines Expressing the Fusion Glycoprotein of HMPV Delivered by Nasal Spray to HPIV3-Seropositive Children 24 to <60 Months of Age

National Institute of Allergy and Infectious Diseases (NIAID)

NCT06531369 NOT YET RECRUITING

Flumazenil Antagonism of Remimazolam in Kidney Transplant Patients

Qianfoshan Hospital

NCT06493500 NOT YET RECRUITING

Efficacy of Formulated Eggshell Derived Nano-hydroxyapatite Containing Toothpaste With and Without Addition of Fluoride vs. Conventional Desensitizing Fluoride Containing Toothpaste in Management of Dentin Hypersensitivity

Cairo University

NCT06368726 ENROLLING BY INVITATION

Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders

Spanish Foundation for Neurometrics Development

NCT06179446 COMPLETED

A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza

Pfizer

NCT05202379 COMPLETED

CC-42344 Safety Study in Healthy Participants

Cocrystal Pharma, Inc.

NCT06602531 COMPLETED

Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults

Arcturus Therapeutics, Inc.

NCT05968989 COMPLETED

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT05755620 COMPLETED

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT03945825 COMPLETED

Flublok or Fluzone With Advax-CpG55.2 or AF03

National Institute of Allergy and Infectious Diseases (NIAID)

NCT06125691 COMPLETED

Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults

Arcturus Therapeutics, Inc.

NCT03816878 COMPLETED

Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals

National Institute of Allergy and Infectious Diseases (NIAID)

NCT04451954 COMPLETED

Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects

Sanofi Pasteur, a Sanofi Company

NCT06507553 COMPLETED

Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older

Sanofi Pasteur, a Sanofi Company

NCT04978454 COMPLETED

Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain

National Institute of Allergy and Infectious Diseases (NIAID)

NCT05818124 COMPLETED

Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019)

Merck Sharp & Dohme LLC

NCT04960397 TERMINATED

Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine

National Institute of Allergy and Infectious Diseases (NIAID)

NCT04144179 COMPLETED

Safety and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Formulations Containing Different H3 Hemagglutinin Antigens in Healthy Adult Subjects 18 to 30 Years of Age

Sanofi Pasteur, a Sanofi Company

NCT04611763 COMPLETED

Effect of Preemptive Analgesia With Flurbiprofen Axetil on Perioperative Sleep Quality and Postoperative Pain in Patients Undergoing Laparoscopic Gynecological Surgery.

Beijing Friendship Hospital

NCT04896086 COMPLETED

First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT05343364 COMPLETED

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease

Phathom Pharmaceuticals, Inc.

NCT05027932 COMPLETED

Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine

National Institute of Allergy and Infectious Diseases (NIAID)

NCT06391177 COMPLETED

A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily

Phathom Pharmaceuticals, Inc.

NCT06643156 COMPLETED

Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

NCT05436444 COMPLETED

Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model

National Institute of Allergy and Infectious Diseases (NIAID)

NCT05446740 COMPLETED

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

GlaxoSmithKline

NCT03898986 COMPLETED

The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets

Stanford University

NCT06476275 COMPLETED

Single Dose Texas 2017 (H3N2) Challenge Study

Duke University

NCT06342349 COMPLETED

A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.

Shanghai Institute Of Biological Products

NCT03888989 TERMINATED

Response to Influenza Vaccine During Pregnancy

Stanford University

NCT02888327 COMPLETED

A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872

Alios Biopharma Inc.

NCT02659735 COMPLETED

A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation

Janssen Research & Development, LLC

NCT03830762 COMPLETED

Xanamem™ in Healthy Elderly Subjects

Actinogen Medical

NCT05875961 COMPLETED

Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults

Seqirus

NCT05155319 COMPLETED

Universal Influenza A Vaccine in Healthy Adults

Emergent BioSolutions

NCT06485401 COMPLETED

To Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function Subjects

Jiaxing AnDiCon Biotech Co.,Ltd

NCT04471038 COMPLETED

Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants

SAb Biotherapeutics, Inc.

NCT03312699 COMPLETED

Effects of Aging on Primary and Secondary Vaccine Responses

Stanford University

NCT06028347 COMPLETED

Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying MRNA Influenza Vaccine in Healthy Adults

Seqirus

NCT05720091 COMPLETED

Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in China

Nanjing Zenshine Pharmaceuticals

NCT05711797 COMPLETED

Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects

Nanjing Zenshine Pharmaceuticals

NCT05955027 COMPLETED

A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects

Nanjing Zenshine Pharmaceuticals

NCT03014310 COMPLETED

H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology

National Institute of Allergy and Infectious Diseases (NIAID)

NCT05223179 COMPLETED

Intramuscular CodaVax-H1N1 in Healthy Adults

Codagenix, Inc

NCT05397119 COMPLETED

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

BlueWillow Biologics

NCT06025773 COMPLETED

A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121

Addpharma Inc.

NCT06167707 COMPLETED

Pharmacokinetics and Pharmacodynamics of Subcutaneous vs Intravenous Furosemide in Healthy Volunteers

scPharmaceuticals, Inc.

NCT05585632 COMPLETED

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

ModernaTX, Inc.

NCT05581407 COMPLETED

Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin

LiteVax BV

NCT06175676 COMPLETED

Safety and Efficacy of Thermosensitive Hydroxybutyl Chitosan and 5-fluorouracil Assisted Endoscopic Dacryocystorhinostomy in the Treatment of Chronic Dacryocystitis

Tianjin Medical University Eye Hospital

NCT06125717 COMPLETED

Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP

Vaxess Technologies

NCT06118151 COMPLETED

Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older

Sanofi Pasteur, a Sanofi Company

NCT05227001 COMPLETED

A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza

Pfizer

NCT04970342 COMPLETED

Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim

Timothy L. Brown

NCT04785794 COMPLETED

Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old

FluGen Inc

NCT05252338 COMPLETED

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults

CureVac

NCT04982913 COMPLETED

Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects

Sunshine Lake Pharma Co., Ltd.

NCT05670444 COMPLETED

Melatonin, Vitamins and Minerals Supplements for the Treatment of Covid-19 and Covid-like Illness

Hôpital Universitaire Sahloul

NCT05765955 COMPLETED

Effects of p38 MAPK Inhibitor POLB 001 on in Vivo LPS Challenge Responses

Poolbeg Pharma plc

NCT04603989 COMPLETED

A Study of HNC042 in Healthy Chinese Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics

Guangzhou Henovcom Bioscience Co. Ltd.

NCT04579250 COMPLETED

Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT04144348 COMPLETED

Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure

ModernaTX, Inc.

NCT05035680 WITHDRAWN

Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion

Gates Medical Research Institute

NCT05163847 COMPLETED

Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults

FluGen Inc

NCT03430089 COMPLETED

Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine

Sanofi Pasteur, a Sanofi Company

NCT05212623 COMPLETED

A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months

Jiangsu Province Centers for Disease Control and Prevention

NCT03594890 COMPLETED

Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects

Osivax

NCT04033406 COMPLETED

Study of VIR-2482 in Healthy Volunteers

Vir Biotechnology, Inc.

NCT05401305 COMPLETED

Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b

St. Petersburg Research Institute of Vaccines and Sera

NCT03814720 COMPLETED

Dose, Safety, Tolerability and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT04690868 COMPLETED

A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131

Addpharma Inc.

NCT03076385 COMPLETED

Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects

ModernaTX, Inc.

NCT03999554 COMPLETED

Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines

FluGen Inc

NCT05126979 COMPLETED

The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 Years

St. Petersburg Research Institute of Vaccines and Sera

NCT05152017 COMPLETED

The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy Volunteers

St. Petersburg Research Institute of Vaccines and Sera

NCT03104725 TERMINATED

Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?

National Institute of Neurological Disorders and Stroke (NINDS)

NCT03553940 COMPLETED

H3N2 M2SR in Pediatric Population

National Institute of Allergy and Infectious Diseases (NIAID)

NCT04439695 COMPLETED

Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults

KBio Inc

NCT04755985 COMPLETED

A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132

Addpharma Inc.

NCT03186781 COMPLETED

Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT03275389 COMPLETED

A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years

GlaxoSmithKline

NCT04044352 COMPLETED

H1N1v Virus Challenge Study in Healthy Subjects

National Institute of Allergy and Infectious Diseases (NIAID)

NCT03448705 COMPLETED

Safety of 4Fluart ID Suspension for Injection in Adult Subjects

Fluart Innovative Vaccine Ltd, Hungary

NCT03300050 COMPLETED

Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine

PATH

NCT04729764 COMPLETED

Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

NCT03345043 COMPLETED

Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult Subjects

ModernaTX, Inc.

NCT04650971 COMPLETED

Study to Assess Safety, Tolerability and Reactogenicity of Vaccine "UniFluVec" After Two Intranasal Administrations in Healthy Volunteers

Pharmenterprises Biotech LLC

NCT04146623 COMPLETED

Safety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal Spray

Codagenix, Inc

NCT03330899 COMPLETED

Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil

Butantan Institute

NCT02822105 COMPLETED

Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers

FluGen Inc

NCT03926416 COMPLETED

Safety Study of Live Attenuated Influenza Vaccine, CodaVax

Codagenix, Inc

NCT04385420 COMPLETED

Phase 1 Study of ATR-002

Atriva Therapeutics GmbH

NCT04372719 COMPLETED

A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers

SGS Life Sciences, a division of SGS Belgium NV

NCT02263547 TERMINATED

Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride

Derrick Scott Robertson

NCT03472976 COMPLETED

H5N1 With or Without Topical Aldara in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT03392389 COMPLETED

Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults

ModernaTX, Inc.

NCT02251288 COMPLETED

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

National Institute of Allergy and Infectious Diseases (NIAID)

NCT04106817 COMPLETED

Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge Virus

WCCT Global

NCT03658135 TERMINATED

BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES

University of California, San Francisco

NCT02594189 COMPLETED

Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers

National Institute of Allergy and Infectious Diseases (NIAID)

NCT02624219 COMPLETED

H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults

National Institute of Allergy and Infectious Diseases (NIAID)

NCT03208101 COMPLETED

A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults

LG Chem

NCT03679143 COMPLETED

The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

NCT02438423 COMPLETED

Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle

Mark Prausnitz

NCT02335164 COMPLETED

A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults

Vaxine Pty Ltd

NCT03038776 COMPLETED

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

Vaxine Pty Ltd

NCT03581903 COMPLETED

A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine

National Institute of Allergy and Infectious Diseases (NIAID)

NCT03651544 COMPLETED

The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

NCT01841307 TERMINATED

Cromolyn Detection of Silent Aspiration

University of California, San Francisco

NCT02598089 COMPLETED

Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S)

Institute of Vaccines and Medical Biologicals, Vietnam

NCT02585700 COMPLETED

A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine

Institute of Virology, Vaccines and Sera, Torlak

NCT03357263 COMPLETED

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults

Green Cross Corporation

NCT02957656 COMPLETED

Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant

National Institute of Allergy and Infectious Diseases (NIAID)

NCT02547792 COMPLETED

Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults

Vaxart

NCT03121339 COMPLETED

Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults

Vaxart

NCT02883426 TERMINATED

Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease

National Institute of Allergy and Infectious Diseases (NIAID)

NCT03459391 COMPLETED

Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers

PHARMENTERPRISES LLC

NCT02988739 COMPLETED

Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine

Pantec Biosolutions AG

NCT02588521 COMPLETED

A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and the Antiviral Activity of Multiple Doses in an Influenza Challenge Study

Alios Biopharma Inc.

NCT02955030 COMPLETED

Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers

Nitto Denko Corporation

NCT03196661 COMPLETED

Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population

Hualan Biological Bacterin Co. Ltd.

NCT02877160 COMPLETED

A Study to Assess the PK of AL-794 Formulations in Healthy Subjects

Alios Biopharma Inc.

NCT02377401 COMPLETED

Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults

GlaxoSmithKline

NCT03028116 COMPLETED

Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine

Research Institute for Biological Safety Problems

NCT02708173 COMPLETED

Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older

Beijing Chaoyang District Centre for Disease Control and Prevention

NCT02177734 WITHDRAWN

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age

GlaxoSmithKline

NCT02269007 COMPLETED

A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China

Jiangsu Province Centers for Disease Control and Prevention

NCT02350751 COMPLETED

Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults

MedImmune LLC

NCT06406790 RECRUITING

CraniSeal Post Approval Study

Pramand LLC

NCT05108818 RECRUITING

Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults

University of Pennsylvania

NCT07384403 RECRUITING

Application of Topical Oxygen Therapy Around Customized Healing Collar

Cairo University

NCT07189091 RECRUITING

CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS

University Hospital, Antwerp

NCT07275060 ACTIVE NOT RECRUITING

Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart

Canadian Immunization Research Network

NCT06995144 RECRUITING

Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure

Sarfez Pharmaceuticals, Inc.

NCT05536856 RECRUITING

Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo

Al-Azhar University

NCT06824779 ACTIVE NOT RECRUITING

Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Responses

Centre Hospitalier Universitaire de Saint Etienne

NCT05455359 RECRUITING

Gastrointestinal Dysmotility on Aspiration Risk

Boston Children's Hospital

NCT07286188 RECRUITING

Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy

Northwestern University

NCT07287137 RECRUITING

Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

Henry M. Jackson Foundation for the Advancement of Military Medicine

NCT07240922 RECRUITING

The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study

The University of Hong Kong

NCT06255886 RECRUITING

Treatment of Gastroesophageal Reflux Disease in Infants

Odense University Hospital

NCT07232745 ACTIVE NOT RECRUITING

Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine

Jiangsu Province Centers for Disease Control and Prevention

NCT01818661 RECRUITING

Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech

Mayo Clinic

NCT07194629 NOT YET RECRUITING

Pilot and Feasibility Study of Impact of SDF 38% Application on Oral Health of Elderly With Autonomy Loss

Université de Montréal

NCT07177417 RECRUITING

Characterizing the Human Airway Immune Response to FluMist Vaccination

Washington University School of Medicine

NCT04101838 RECRUITING

B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults

University of Alabama at Birmingham

NCT05045612 RECRUITING

Antibiotic Therapy in Viral Airway Infections

University Hospital, Akershus

NCT06999577 RECRUITING

The Mechanism Versus PPI Trial

University of California, San Diego

NCT04487041 RECRUITING

Tfh Dysfunction in HIV and Aging

University of Miami

NCT03129490 ACTIVE NOT RECRUITING

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation

Herlev and Gentofte Hospital

NCT05320796 RECRUITING

The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass

Prof Urs Zingg

NCT06949878 NOT YET RECRUITING

21% Hydrochloric Acid Based Versus 6.6 % Hydrochloric Based Micro Abrasive Kit in Management of Patients With Mild to Moderate Fluorosis

Cairo University

NCT02714634 RECRUITING

Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide

University Hospital, Strasbourg, France

NCT03753347 ACTIVE NOT RECRUITING

TITRE III: Influenza B Immunogenicity Investigation

British Columbia Centre for Disease Control

NCT04180397 RECRUITING

Controlled Fluid Removal in Critical Ill Patients With Fluid Overload in the Intensive Care Unit.

Morten H. Bestle

NCT05629143 ACTIVE NOT RECRUITING

Primary carE PPi dEprescRibing Trial

Universitaire Ziekenhuizen KU Leuven

NCT06734195 NOT YET RECRUITING

Comparing the Synergistic Effect of Caudal Dexmedetomidine and Propofol Versus Caudal Dexmedetomidine Only or Propofol Only in Prevention of Sevoflurane Related Emergence Agitation in Pediatric Patients Undergoing Congenital Inguinal Hernia Repair

Assiut University

NCT06664008 NOT YET RECRUITING

The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease

Ain Shams University

NCT05518500 RECRUITING

A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults

The Jackson Laboratory

NCT06560268 NOT YET RECRUITING

Low Flow Anesthesia in Children Undergoing Strabismus Surgery

Cukurova University

NCT06430047 RECRUITING

Efficacy and Safety of EsoDuo®

Chong Kun Dang Pharmaceutical

NCT04998344 ACTIVE NOT RECRUITING

An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh

University of Bergen

NCT06091410 ACTIVE NOT RECRUITING

Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines

Catholic Kwandong University

NCT05705115 RECRUITING

Acetated Ringer´s Solution in Experimental Hypovolemia

Oslo University Hospital

NCT06286488 ACTIVE NOT RECRUITING

Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza

Medical University of Warsaw

NCT05616546 RECRUITING

Bone Marrow and Peripheral Blood Immune Responses Study

Emory University

NCT04436978 RECRUITING

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

St. Antonius Hospital

NCT03330132 ACTIVE NOT RECRUITING

Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong

The University of Hong Kong

NCT02957890 ACTIVE NOT RECRUITING

Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong

The University of Hong Kong

NCT04164212 COMPLETED

Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection

University of Alabama at Birmingham

NCT06567860 COMPLETED

Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations

La Jolla Institute for Immunology

NCT07359508 COMPLETED

Effect of Desflurane v/s Propofol on the Optic Nerve Sheath Diameter

All India Institute of Medical Sciences

NCT03598439 COMPLETED

Randomized Influenza Vaccine Evaluation of Immune Response

Marshfield Clinic Research Foundation

NCT06501963 COMPLETED

Revealing Protective Immunity to Influenza Using Systems Immunology

Emory University

NCT04216784 TERMINATED

Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic Patients

Rush University Medical Center

NCT05517174 COMPLETED

A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults

Tor Biering-Sørensen

NCT04109222 COMPLETED

Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively

Sanofi Pasteur, a Sanofi Company

NCT06506812 COMPLETED

Pooled Analysis of Methodologically Harmonized Pragmatic Randomized Trials of High-Dose vs. Standard-Dose Influenza Vaccine Against Severe Clinical Outcomes

Tor Biering-Sørensen

NCT06141655 COMPLETED

HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia

Federico Martinón Torres

NCT07108881 COMPLETED

Ultrasound Guided Fluid Loading Before Spinal Anesthesia

University Tunis El Manar

NCT06161454 COMPLETED

Xofluza-Wearables Feasibility-Study

Children's Hospital of Philadelphia

NCT06841913 SUSPENDED

Woodsmoke Exposure, Influenza Infection, and Nasal Immunity

University of North Carolina, Chapel Hill

NCT06518577 COMPLETED

Immunogenicity of Influenza Vaccinations

Duke University

NCT06020118 COMPLETED

Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations

Duke University

NCT06987942 COMPLETED

Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)

Sinovac (Dalian) Vaccine Technology Co., Ltd.

NCT04512950 COMPLETED

Crystalloid FLUID Choices for Resuscitation of Hospitalized Patients

Ottawa Hospital Research Institute

NCT06609811 COMPLETED

The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine

Jiangsu Province Centers for Disease Control and Prevention

NCT05648357 COMPLETED

A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India

GlaxoSmithKline

NCT06716567 COMPLETED

Maternal Determinants of Immunity to Influenza

Centre Hospitalier Universitaire Saint Pierre

NCT05514002 TERMINATED

Comparison of Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

Fatimah Dawood

NCT05391893 COMPLETED

Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation

Corewell Health South

NCT02871206 COMPLETED

Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children

McMaster University

NCT03160118 COMPLETED

Study of Biomarkers of Immune Activation Associated with Symptoms and Immune Responses After Influenza Vaccination in Adults

University Hospital, Ghent

NCT03722589 COMPLETED

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

Centers for Disease Control and Prevention

NCT04978818 COMPLETED

Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)

Johns Hopkins Bloomberg School of Public Health

NCT05371600 COMPLETED

Preoperative Anxiolysis With Intravenous Midazolam on Intraoperative Sevoflurane Gas Consumption

Cukurova University

NCT03694808 COMPLETED

FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care

David H. Canaday

NCT03735147 COMPLETED

Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children

Imperial College London

NCT04887389 COMPLETED

Cariostatic and Remineralizing Effects of Three Different Dental Varnishes

Nisreen Ibrahim khan

NCT03777163 COMPLETED

Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine

Butantan Institute

NCT06252051 COMPLETED

Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD)

Universitas Padjadjaran

NCT03688620 COMPLETED

Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season

GlaxoSmithKline

NCT04028466 TERMINATED

Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features

St. Luke's Medical Center, Philippines

NCT03884296 WITHDRAWN

Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood

Stanford University

NCT03898973 WITHDRAWN

Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood

Stanford University

NCT04523324 COMPLETED

Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel

Centers for Disease Control and Prevention

NCT04187196 COMPLETED

Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion

Wake Forest University Health Sciences

NCT02385123 TERMINATED

Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers

National Institute of Allergy and Infectious Diseases (NIAID)

NCT02485639 TERMINATED

Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination

National Institute of Allergy and Infectious Diseases (NIAID)

NCT05512494 COMPLETED

Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated

Sinovac Biotech Co., Ltd

NCT05138705 COMPLETED

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years

Shanghai Institute Of Biological Products

NCT05486377 COMPLETED

Remimazolam vs Desflurane for General Anesthesia for Ablation of Arrhythmia

Seoul National University Bundang Hospital

NCT04126486 COMPLETED

A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke

Bristol-Myers Squibb

NCT03603509 COMPLETED

Gene Signatures of Influenza Vaccine Responses in Older Adults

Mayo Clinic

NCT05391607 COMPLETED

Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement

Insel Gruppe AG, University Hospital Bern

NCT02882100 COMPLETED

Adjuvanted Influenza Vaccination in U.S. Nursing Homes

Insight Therapeutics, LLC

NCT02986685 WITHDRAWN

Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole

Xijing Hospital of Digestive Diseases

NCT03824847 SUSPENDED

Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community

The University of Hong Kong

NCT04091880 COMPLETED

Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine

China National Biotec Group Company Limited

NCT05313893 COMPLETED

A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years

Jiangsu Province Centers for Disease Control and Prevention

NCT04997239 COMPLETED

A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old

Sinovac Biotech Co., Ltd

NCT04559204 COMPLETED

Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

China National Biotec Group Company Limited

NCT05267743 COMPLETED

Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease

HK inno.N Corporation

NCT05471531 COMPLETED

Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine

Sinovac Biotech Co., Ltd

NCT03686514 TERMINATED

The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics

Emory University

NCT04133584 COMPLETED

The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine

Zhejiang Provincial Center for Disease Control and Prevention

NCT04077424 COMPLETED

Senescent Immunity in Elders and Vaccine Responses (SILVER)

Vanderbilt University Medical Center

NCT04141917 TERMINATED

Test-and-treat for Influenza in Homeless Shelters

University of Washington

NCT03344029 COMPLETED

Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years

Sanofi

NCT02908269 COMPLETED

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations

Sanofi Pasteur, a Sanofi Company

NCT03308825 COMPLETED

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines

Sanofi Pasteur, a Sanofi Company

NCT02915302 COMPLETED

Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children

Sanofi Pasteur, a Sanofi Company

NCT03546192 COMPLETED

Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)

Sanofi Pasteur, a Sanofi Company

NCT03617523 COMPLETED

Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2018-2019 Formulations

Sanofi Pasteur, a Sanofi Company

NCT03673345 COMPLETED

Development of Childhood Anti-Influenza Immunity

National Institute of Allergy and Infectious Diseases (NIAID)

NCT04309916 COMPLETED

Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance

HK inno.N Corporation

NCT03068949 COMPLETED

Comparison of Three Licensed Influenza Vaccines

University of Rochester

NCT03746002 TERMINATED

Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing

University of Maryland, Baltimore

NCT04790851 COMPLETED

Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4

China National Biotec Group Company Limited

NCT03982069 COMPLETED

Immunologic Response to FluMist vs. Flucelvax

Richard Zimmerman MD

NCT02831608 COMPLETED

Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis

Ole Frobert, MD, PhD

NCT03656198 COMPLETED

Non-specific Effects of Rabies Vaccine

Ross University School of Veterinary Medicine

NCT04141930 COMPLETED

Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle

University of Washington

NCT04801888 COMPLETED

Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

Sinovac Research and Development Co., Ltd.

NCT04122560 COMPLETED

Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration

Radboud University Medical Center

NCT03200600 TERMINATED

Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery

Peking University First Hospital

NCT04898270 COMPLETED

Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients

Taichung Veterans General Hospital

NCT03328325 COMPLETED

Age and Response to Flu Vaccines

National Institute of Allergy and Infectious Diseases (NIAID)

NCT03573999 COMPLETED

Effect of Mannitol 20% Versus Hypertonic Saline 7.5% in Brain Metabolism and Oxygenation

Aristotle University Of Thessaloniki

NCT03600428 COMPLETED

Safety of LAIV4 in Children With Asthma

Vanderbilt University Medical Center

NCT04788485 COMPLETED

Evaluation of Smectite Effect As A Food Thickener On Gastroesophageal Reflux Disease In Neonates Using Combined Esophageal Multichannel Intraluminal Impedance

Ain Shams Maternity Hospital

NCT03410862 COMPLETED

Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza

michael macknin

NCT02907632 COMPLETED

Methoclopramide for Gastroesophageal Reflux in Premature Infants

Nathalie Charpak

NCT04522635 COMPLETED

Fluid Mobilization in Hospitalized Patients With Acute Kidney Injury

University of California, San Diego

NCT01850446 COMPLETED

Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

Materia Medica Holding

NCT03659201 COMPLETED

Efficacy and Safety of Neosil on Chronic Effluvium

EMS

NCT03244982 SUSPENDED

Fluorescein Angiography With a Full-dose Versus a Half-dose of Intravenous Fluorescein

Kresge Eye Institute

NCT03701061 COMPLETED

Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response

Emory University

NCT02972957 COMPLETED

A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia

London School of Hygiene and Tropical Medicine

NCT03848507 COMPLETED

Impact of Hyperoncotic Albumin to Support Blood Loss Replacement

Insel Gruppe AG, University Hospital Bern

NCT03614975 COMPLETED

Immunologic Response to Influenza Vaccination in Children and Adolescents

Richard Zimmerman MD

NCT02853929 COMPLETED

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

GlaxoSmithKline

NCT03564444 COMPLETED

D2560C00015 FluMist Annual Safety Study 2018

MedImmune LLC

NCT03928470 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

Chong Kun Dang Pharmaceutical

NCT02549365 COMPLETED

Efficacy & Safety of Nasal Influenza Immunisation in Children

Imperial College London

NCT02609399 COMPLETED

ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir

Johns Hopkins University

NCT03104790 COMPLETED

Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls

Public Health England

NCT03370289 COMPLETED

A Phase 4 Post-marketing Study of Intramuscular Injections of BLB-750 in Healthy Adult Subjects

Takeda

NCT03163342 COMPLETED

Immune Response Following Seasonal Influenza Vaccination

Altimmune, Inc.

NCT03116841 COMPLETED

Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation

Takeda

NCT03172988 TERMINATED

Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery

Peking University First Hospital

NCT03335124 TERMINATED

The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock

University Medical Centre Ljubljana

NCT03181464 WITHDRAWN

Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics

Washington University School of Medicine

NCT02592486 COMPLETED

The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine

Kameda Medical Center

NCT03158038 COMPLETED

Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season

MedImmune LLC

NCT02876159 COMPLETED

The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination

Emory University

NCT03143101 COMPLETED

Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age

MedImmune LLC

NCT03767296 COMPLETED

Influence of a Bolus Administration of Ephedrine and Phenylephrine on the Spinal Oxygen Saturation, Measured With NIRS.

University Hospital, Ghent

NCT03761485 COMPLETED

Dental Fluorosis Risk by the Use of Acidulated Fluoride Dentifrice

Federal University of Paraíba

NCT02794844 COMPLETED

Implementation of PPI Medication PGX Testing

Nemours Children's Clinic

NCT03746691 COMPLETED

Effect of Citalopram on Reflux Episodes in Healthy Volunteers

Universitaire Ziekenhuizen KU Leuven

NCT03133767 COMPLETED

Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation

Nicholas M Mohr

NCT03654937 COMPLETED

Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes

Universität des Saarlandes

NCT03080831 COMPLETED

TOnicity of Perioperative Maintenance SoluTions

Niels Van Regenmortel

NCT02530879 WITHDRAWN

Comparison of Voice Therapy and Antireflex Therapy in LPR

Temple University

NCT03502291 COMPLETED

The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage Study

Liverpool University Hospitals NHS Foundation Trust

NCT03149419 COMPLETED

Hot Flash as a Marker of Cardiovascular Risk in Recent Postmenopause: Effects of Non-hormonal Treatments

Rio de Janeiro State University

NCT02655874 COMPLETED

Tropical Influenza Control Strategies for the Elderly

Tan Tock Seng Hospital

NCT02743117 COMPLETED

Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season

MedImmune LLC

NCT02988063 WITHDRAWN

Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs

OhioHealth

NCT02561169 TERMINATED

A Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza

McMaster University

NCT02458157 TERMINATED

Forced Fluid Removal in High Risk Acute Kidney Injury

Nordsjaellands Hospital

NCT03199430 COMPLETED

Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism.

Swansea University

NCT03023709 TERMINATED

Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032)

Stanford University

NCT02776280 COMPLETED

Oral Fluoride Bioavailability by the Consumption of Meals Prepared With Fluoridated Water or Salt

University of Campinas, Brazil

NCT02560909 COMPLETED

Adjuvanted Influenza Vaccine in Stem Cell Transplant

University Health Network, Toronto

NCT02563093 COMPLETED

Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults

Sanofi Pasteur, a Sanofi Company

NCT02539108 COMPLETED

Safety and Immunogenicity of the 2015-2016 Formulation of Fluzone® Quadrivalent (Influenza Vaccine) Among Healthy Children

Sanofi Pasteur, a Sanofi Company

NCT02473510 COMPLETED

Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season

MedImmune LLC

NCT02723812 COMPLETED

Evaluate Safety of GCFLU® Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years Old

Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products

Data: ClinicalTrials.gov